{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "439",
                "460"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Obserwacja w kierunku"
        },
        {
            "identifier": "T2",
            "position": [
                "461",
                "481"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zaburze\u0144 rytmu serca"
        },
        {
            "identifier": "T3",
            "position": [
                "593",
                "599"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Gutron"
        },
        {
            "identifier": "T4",
            "position": [
                "600",
                "622"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "2 x 1/2 tabl. a 2,5 mg"
        },
        {
            "identifier": "T5",
            "position": [
                "625",
                "659"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "kontrola w Poradni Kardiologicznej"
        },
        {
            "identifier": "T6",
            "position": [
                "660",
                "669"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za 3 m-ce"
        },
        {
            "identifier": "T7",
            "position": [
                "808",
                "826"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "incydentami omdle\u0144"
        },
        {
            "icd": "ICD10:I49.9",
            "identifier": "N1",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Zaburzenia rytmu serca, nieokre\u00c5\u009blone"
        },
        {
            "icd": "ICD10:R55",
            "identifier": "N2",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Omdlenie i zapa\u00c5\u009b\u00c4\u0087"
        },
        {
            "arg1": "T3",
            "arg2": "T4",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T5",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "identifier": "A1",
            "referenced": "T2",
            "subtype": "Source",
            "type": "A",
            "value": "Declared"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 16 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Obserwacja w kierunku zaburze\u0144 rytmu serca.\n------------------------------------------------\nZalecenia\n------------------------------------------------\n- Gutron 2 x 1/2 tabl. a 2,5 mg\n- kontrola w Poradni Kardiologicznej za 3 m-ce\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z incydentami omdle\u0144 przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:6.28[10\\\\^3/ul]\n    RBC:4.71[10\\\\^6/ul]\n    HGB:12.6[g/dl]\n    HCT:38.3[%]\n    MCV:81.3[fl]\n    MCH:26.8[pg]\n    MCHC:32.9[g/dl]\n    PLT:189.0[10\\\\^3/ul]\n    RDW-SD:38.0[fl]\n    RDW-CV:12.9[%]\n    PDW:16.3[fl]\n    MPV:12.1[fl]\n    P-LCR:41.1[%]\n    PCT:0.2[%]\n    NEUTR#:3.19[10\\\\^3/ul]\n    NEUTR%:50.7[%]\n    LYMPH#:2.38[10\\\\^3/ul]\n    LYMPH%:37.9[%]\n    MONO#:0.52[10\\\\^3/ul]\n    MONO%:8.30[%]\n    EO#:0.13[10\\\\^3/ul]\n    EO%:2.10[%]\n    BASO#:0.06[10\\\\^3/ul]\n    BASO%:1.00[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nKwas mlekowy: LAC:16.90[mg/dl]\nKwas mlekowy: LAC:73.40[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nKreatynina: CREA:0.80[mg/dl]\nMocznik: UREA:28.00[mg/dl]\nASPAT: AST:23.00[IU/L]\nALAT: ALT:22.00[IU/L]\nNT- proBNP\n    NTpBNP:\n    20.00[pg/ml]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:84.7[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:164[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:112.8[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nI49.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n89.41\n89.541\n------------------------------------------------"
}